272 related articles for article (PubMed ID: 9224629)
1. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):53-61. PubMed ID: 9224629
[TBL] [Abstract][Full Text] [Related]
2. Asp7O in the peripheral anionic site of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Eur J Biochem; 1996 Jan; 235(1-2):36-48. PubMed ID: 8631355
[TBL] [Abstract][Full Text] [Related]
3. Aging of di-isopropyl-phosphorylated human butyrylcholinesterase.
Masson P; Fortier PL; Albaret C; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):601-7. PubMed ID: 9359435
[TBL] [Abstract][Full Text] [Related]
4. Hydration change during the aging of phosphorylated human butyrylcholinesterase: importance of residues aspartate-70 and glutamate-197 in the water network as probed by hydrostatic and osmotic pressures.
Masson P; Cléry C; Guerra P; Redslob A; Albaret C; Fortier PL
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):361-9. PubMed ID: 10510301
[TBL] [Abstract][Full Text] [Related]
5. Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters.
Masson P; Froment MT; Fortier PL; Visicchio JE; Bartels CF; Lockridge O
Biochim Biophys Acta; 1998 Sep; 1387(1-2):41-52. PubMed ID: 9748494
[TBL] [Abstract][Full Text] [Related]
6. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
7. Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase.
Neville LF; Gnatt A; Loewenstein Y; Soreq H
J Neurosci Res; 1990 Dec; 27(4):452-60. PubMed ID: 2079709
[TBL] [Abstract][Full Text] [Related]
8. Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico and in vitro models.
Iqbal A; Malik S; Nurulain SM; Musilek K; Kuca K; Kalasz H; Fatmi MQ
Chem Biol Interact; 2019 Sep; 310():108735. PubMed ID: 31276662
[TBL] [Abstract][Full Text] [Related]
9. Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes.
Ashani Y; Radić Z; Tsigelny I; Vellom DC; Pickering NA; Quinn DM; Doctor BP; Taylor P
J Biol Chem; 1995 Mar; 270(11):6370-80. PubMed ID: 7890775
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.
Masson P; Froment MT; Gillon E; Nachon F; Lockridge O; Schopfer LM
FEBS J; 2008 May; 275(10):2617-31. PubMed ID: 18422653
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides.
Masson P; Froment MT; Gillon E; Nachon F; Darvesh S; Schopfer LM
Biochim Biophys Acta; 2007 Sep; 1774(9):1139-47. PubMed ID: 17690023
[TBL] [Abstract][Full Text] [Related]
12. Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior.
Masson P; Bec N; Froment MT; Nachon F; Balny C; Lockridge O; Schopfer LM
Eur J Biochem; 2004 May; 271(10):1980-90. PubMed ID: 15128307
[TBL] [Abstract][Full Text] [Related]
13. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants.
Schwarz M; Loewenstein-Lichtenstein Y; Glick D; Liao J; Norgaard-Pedersen B; Soreq H
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):101-10. PubMed ID: 7476018
[TBL] [Abstract][Full Text] [Related]
14. Absence of a protective effect of the oxime 2-PAM toward paraoxon-poisoned honey bees: acetylcholinesterase reactivation not at fault.
Polyzou A; Froment MT; Masson P; Belzunces LP
Toxicol Appl Pharmacol; 1998 Sep; 152(1):184-92. PubMed ID: 9772214
[TBL] [Abstract][Full Text] [Related]
15. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
16. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
Worek F; Thiermann H; Szinicz L
Arch Toxicol; 2004 Apr; 78(4):212-7. PubMed ID: 14647978
[TBL] [Abstract][Full Text] [Related]
17. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds.
Bušić V; Katalinić M; Šinko G; Kovarik Z; Gašo-Sokač D
Toxicol Lett; 2016 Nov; 262():114-122. PubMed ID: 27693733
[TBL] [Abstract][Full Text] [Related]
18. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
[TBL] [Abstract][Full Text] [Related]
19. [Reactivation and aging of acetylcholinesterase in human brain inhibited by phoxim and phoxim oxon in vitro].
Li J; Zhang Y; Du X; Sun M
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Sep; 36(5):311-4. PubMed ID: 12411190
[TBL] [Abstract][Full Text] [Related]
20. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
